202 related articles for article (PubMed ID: 33649241)
1. Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis.
Piccolo P; Ferriero R; Barbato A; Attanasio S; Monti M; Perna C; Borel F; Annunziata P; Carissimo A; De Cegli R; Quagliata L; Terracciano LM; Housset C; Teckman JH; Mueller C; Brunetti-Pierri N
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649241
[TBL] [Abstract][Full Text] [Related]
2. CHOP and c-JUN up-regulate the mutant Z α
Attanasio S; Ferriero R; Gernoux G; De Cegli R; Carissimo A; Nusco E; Campione S; Teckman J; Mueller C; Piccolo P; Brunetti-Pierri N
J Biol Chem; 2020 Sep; 295(38):13213-13223. PubMed ID: 32723872
[TBL] [Abstract][Full Text] [Related]
3. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
[TBL] [Abstract][Full Text] [Related]
4. Activation of the c-Jun N-terminal kinase pathway aggravates proteotoxicity of hepatic mutant Z alpha1-antitrypsin.
Pastore N; Attanasio S; Granese B; Castello R; Teckman J; Wilson AA; Ballabio A; Brunetti-Pierri N
Hepatology; 2017 Jun; 65(6):1865-1874. PubMed ID: 28073160
[TBL] [Abstract][Full Text] [Related]
5. Regulation of PGC1α Downstream of the Insulin Signaling Pathway Plays a Role in the Hepatic Proteotoxicity of Mutant α1-Antitrypsin Deficiency Variant Z.
Rudnick DA; Huang J; Hidvegi T; Chu AS; Hale P; Munanairi A; Dietzen DJ; Cliften PF; Tycksen E; Lutkewitte AJ; Finck BN; Pak SC; Silverman GA; Perlmutter DH
Gastroenterology; 2022 Jul; 163(1):270-284. PubMed ID: 35301011
[TBL] [Abstract][Full Text] [Related]
6. Potential role for EZH2 in promotion of asthma through suppression of miR-34b transcription by inhibition of FOXO3.
Liu B; Sun H; Wang J; Liu H; Zhao C
Lab Invest; 2021 Aug; 101(8):998-1010. PubMed ID: 33941868
[TBL] [Abstract][Full Text] [Related]
7. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH
Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
[TBL] [Abstract][Full Text] [Related]
9. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
[TBL] [Abstract][Full Text] [Related]
10. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
Brunt EM; Blomenkamp K; Ahmed M; Ali F; Marcus N; Teckman J
J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):626-30. PubMed ID: 20890217
[TBL] [Abstract][Full Text] [Related]
11. Resolution of hepatic fibrosis after ZFN-mediated gene editing in the PiZ mouse model of human α1-antitrypsin deficiency.
Li Y; Guha C; Asp P; Wang X; Tchaikovskya TL; Kim K; Mendel M; Cost GJ; Perlmutter DH; Roy-Chowdhury N; Fox IJ; Conway A; Roy-Chowdhury J
Hepatol Commun; 2023 Mar; 7(3):e0070. PubMed ID: 36848094
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype.
Bjursell M; Porritt MJ; Ericson E; Taheri-Ghahfarokhi A; Clausen M; Magnusson L; Admyre T; Nitsch R; Mayr L; Aasehaug L; Seeliger F; Maresca M; Bohlooly-Y M; Wiseman J
EBioMedicine; 2018 Mar; 29():104-111. PubMed ID: 29500128
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-122-5p promotes renal fibrosis and injury in spontaneously hypertensive rats by targeting FOXO3.
Liu Y; Dong ZJ; Song JW; Liang LR; Sun LL; Liu XY; Miao R; Xu YL; Li XT; Zhang MW; Zhang ZZ; Zhong JC
Exp Cell Res; 2022 Feb; 411(2):113017. PubMed ID: 34998813
[TBL] [Abstract][Full Text] [Related]
14. FoxO3 Modulates LPS-Activated Hepatic Inflammation in Turbot (
Pan M; Liu J; Huang D; Guo Y; Luo K; Yang M; Gao W; Xu Q; Zhang W; Mai K
Front Immunol; 2021; 12():679704. PubMed ID: 34276667
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of hepatocyte nuclear factor-4α and defective zonation in livers expressing mutant Z α1-antitrypsin.
Piccolo P; Annunziata P; Soria LR; Attanasio S; Barbato A; Castello R; Carissimo A; Quagliata L; Terracciano LM; Brunetti-Pierri N
Hepatology; 2017 Jul; 66(1):124-135. PubMed ID: 28295475
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Z Mutant Alpha-1 Antitrypsin In Vivo Using Modified DNA Antisense Oligonucleotides.
Aghajan M; Guo S; Monia BP
Methods Mol Biol; 2017; 1639():127-138. PubMed ID: 28752452
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency.
Pastore N; Blomenkamp K; Annunziata F; Piccolo P; Mithbaokar P; Maria Sepe R; Vetrini F; Palmer D; Ng P; Polishchuk E; Iacobacci S; Polishchuk R; Teckman J; Ballabio A; Brunetti-Pierri N
EMBO Mol Med; 2013 Mar; 5(3):397-412. PubMed ID: 23381957
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/α-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy.
Feng L; Zhang J; Zhu N; Ding Q; Zhang X; Yu J; Qiang W; Zhang Z; Ma Y; Huang D; Shen Y; Fang S; Yu Y; Wang H; Shen Y
Autophagy; 2017 Apr; 13(4):686-702. PubMed ID: 28121484
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1-antitrypsin.
Baligar P; Kochat V; Arindkar SK; Equbal Z; Mukherjee S; Patel S; Nagarajan P; Mohanty S; Teckman JH; Mukhopadhyay A
Hepatology; 2017 Apr; 65(4):1319-1335. PubMed ID: 28056498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
